Drug Search Results
More Filters [+]

Pemoline

Alternative Names: pemoline, cylert
Latest Update: 2017-01-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Brazil | Chile | Ireland | New Zealand | Peru | Taiwan | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: National Institute on Drug Abuse (NIDA)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pemoline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Cocaine-Related Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NIDA-09250-7

P2

Completed

Cocaine-Related Disorders

1999-08-01

NIDA-3-0010-5

P2

Withdrawn

Cocaine-Related Disorders

None

Recent News Events

Date

Type

Title